CN102043046B - 一种检测糖链异常IgA肾病的蛋白芯片 - Google Patents
一种检测糖链异常IgA肾病的蛋白芯片 Download PDFInfo
- Publication number
- CN102043046B CN102043046B CN201010299137.3A CN201010299137A CN102043046B CN 102043046 B CN102043046 B CN 102043046B CN 201010299137 A CN201010299137 A CN 201010299137A CN 102043046 B CN102043046 B CN 102043046B
- Authority
- CN
- China
- Prior art keywords
- sugar chain
- protein chip
- protein
- iga
- chip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 44
- 230000002159 abnormal effect Effects 0.000 title claims abstract description 27
- 208000017169 kidney disease Diseases 0.000 title claims abstract description 15
- 101710186708 Agglutinin Proteins 0.000 claims description 15
- 101710146024 Horcolin Proteins 0.000 claims description 15
- 101710189395 Lectin Proteins 0.000 claims description 15
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 15
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 15
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 15
- 239000000910 agglutinin Substances 0.000 claims description 15
- 240000002895 Vicia hirsuta Species 0.000 claims description 8
- 239000004425 Makrolon Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920000515 polycarbonate Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 8
- 108090001090 Lectins Proteins 0.000 abstract 4
- 102000004856 Lectins Human genes 0.000 abstract 4
- 239000002523 lectin Substances 0.000 abstract 4
- 241000237858 Gastropoda Species 0.000 abstract 1
- 108010038211 Vicia lectins Proteins 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 description 20
- 108090000288 Glycoproteins Proteins 0.000 description 20
- 210000002966 serum Anatomy 0.000 description 13
- 239000007788 liquid Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 201000008383 nephritis Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 6
- 239000012925 reference material Substances 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 239000013558 reference substance Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 206010001580 Albuminuria Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 208000022461 Glomerular disease Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000011862 kidney biopsy Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108010041397 CD4 Antigens Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002482 oligosaccharides Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 125000005629 sialic acid group Chemical group 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 108010053481 Antifreeze Proteins Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000025760 Benign familial haematuria Diseases 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 229920002306 Glycocalyx Polymers 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000005777 Lupus Nephritis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000012010 Sialomucins Human genes 0.000 description 1
- 108010061228 Sialomucins Proteins 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
- -1 carrier Proteins 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 210000002601 glomerular mesangium Anatomy 0.000 description 1
- 210000004517 glycocalyx Anatomy 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010299137.3A CN102043046B (zh) | 2009-10-13 | 2010-09-30 | 一种检测糖链异常IgA肾病的蛋白芯片 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910308226.7 | 2009-10-13 | ||
CN200910308226 | 2009-10-13 | ||
CN201010299137.3A CN102043046B (zh) | 2009-10-13 | 2010-09-30 | 一种检测糖链异常IgA肾病的蛋白芯片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102043046A CN102043046A (zh) | 2011-05-04 |
CN102043046B true CN102043046B (zh) | 2014-05-07 |
Family
ID=43909388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010299137.3A Active CN102043046B (zh) | 2009-10-13 | 2010-09-30 | 一种检测糖链异常IgA肾病的蛋白芯片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102043046B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104678103A (zh) * | 2014-08-05 | 2015-06-03 | 首都医科大学附属北京佑安医院 | 检测血清糖蛋白岩藻糖指数的化学发光蛋白芯片、试剂盒及检测方法 |
CN108398550B (zh) * | 2018-03-07 | 2022-07-26 | 深圳市伯劳特生物制品有限公司 | 一种组合物、芯片及其制备方法和包含有该芯片的检测装置 |
CN110031632A (zh) * | 2019-04-03 | 2019-07-19 | 中国医学科学院北京协和医院 | 一种反映IgG4相关性疾病的疾病活动性的生物标志物及其用途 |
CN110045127A (zh) * | 2019-04-03 | 2019-07-23 | 中国医学科学院北京协和医院 | 一种IgG4相关性疾病多器官受累的生物标志物及其用途 |
CN110045125B (zh) * | 2019-04-03 | 2022-08-09 | 中国医学科学院北京协和医院 | 一种用于诊断腹膜后纤维化的生物标志物及其用途 |
CN112129946A (zh) * | 2020-08-16 | 2020-12-25 | 陆修委 | 无糖链型惰性蛋白封闭剂的制备方法及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1388377A (zh) * | 2002-07-01 | 2003-01-01 | 西安联尔生物技术有限公司 | 一种用于检测各种疾病特定指标的抗原抗体芯片 |
CN101019027A (zh) * | 2004-09-14 | 2007-08-15 | 三菱化学株式会社 | 生物材料结构体及其制造方法、生物材料担载体、对象物质的精制方法、亲合层析用容器、分离用芯片、对象物质的解析方法、对象物质的解析用分离装置、生物材料复合体、生物材料复合体担载体、传感器芯片、固定有生物材料的固相载体及其制造方法、生物材料固定化试剂盒、新固相载体及其制造方法和应用 |
CN101051010A (zh) * | 2007-05-17 | 2007-10-10 | 北京热景生物技术有限公司 | 一种检测糖链异常IgA肾病的装置及应用此装置的试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051354A (en) * | 1988-04-15 | 1991-09-24 | Abbott Laboratories | Detection of altered IGA1 in fluid samples |
CN1156703C (zh) * | 2001-11-08 | 2004-07-07 | 郭占军 | 生物化学型蛋白质芯片及其制作方法 |
-
2010
- 2010-09-30 CN CN201010299137.3A patent/CN102043046B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1388377A (zh) * | 2002-07-01 | 2003-01-01 | 西安联尔生物技术有限公司 | 一种用于检测各种疾病特定指标的抗原抗体芯片 |
CN101019027A (zh) * | 2004-09-14 | 2007-08-15 | 三菱化学株式会社 | 生物材料结构体及其制造方法、生物材料担载体、对象物质的精制方法、亲合层析用容器、分离用芯片、对象物质的解析方法、对象物质的解析用分离装置、生物材料复合体、生物材料复合体担载体、传感器芯片、固定有生物材料的固相载体及其制造方法、生物材料固定化试剂盒、新固相载体及其制造方法和应用 |
CN101051010A (zh) * | 2007-05-17 | 2007-10-10 | 北京热景生物技术有限公司 | 一种检测糖链异常IgA肾病的装置及应用此装置的试剂盒 |
Non-Patent Citations (4)
Title |
---|
A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome;Kanoelani T. Pilobello et al.,;《PNAS》;20070710;第104卷(第28期);具体参见第11539页第1栏第1段 * |
Atsushi Kuno等.Evanescent-field fluorenscence-assisted lectin microarray: a new strategy for glycan profiling.《NATURE METHODS》.2005,第2卷(第11期), |
Evanescent-field fluorenscence-assisted lectin microarray: a new strategy for glycan profiling;Atsushi Kuno等;《NATURE METHODS》;20051021;第2卷(第11期);第851-856页 * |
Kanoelani T. Pilobello et al.,.A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome.《PNAS》.2007,第104卷(第28期), |
Also Published As
Publication number | Publication date |
---|---|
CN102043046A (zh) | 2011-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102043046B (zh) | 一种检测糖链异常IgA肾病的蛋白芯片 | |
WO2008031288A1 (fr) | Colonne centrifuge préremplie servant à dépister un variant d'alpha-fétoprotéine spécifique de l'hépatocarcinome, et trousse d'analyse contenant ladite colonne | |
IT8047743A1 (it) | Procedimento e corredo per determinare il livello di glicolegami associati a tumore. | |
CN101657550A (zh) | 用于诊断阑尾炎的方法和设备 | |
Gomes et al. | Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study | |
EP2908136A1 (en) | Method and kit for distinguishing between prostate carcinoma and benign prostatic hyperplasia | |
EP0311492B1 (fr) | Trousse et méthode de dosage immunométrique applicables à des cellules entières | |
WO2013078767A1 (zh) | 一种测定蛋白中糖基的方法 | |
CN105717308A (zh) | 快速定量检测粪便乳铁蛋白的免疫层析试剂盒 | |
Wu et al. | Binding profile of Artocarpus integrifolia agglutinin (Jacalin) | |
CN101718785B (zh) | 直接抗人球蛋白试剂卡的制备方法 | |
Wu et al. | Recognition profile of Bauhinia purpurea agglutinin (BPA) | |
EP3832306B1 (en) | METHOD FOR IMMUNOLOGICAL ANALYSIS OF (1->3)-ß-D-GLUCAN IN BIOLOGICAL SAMPLE, KIT FOR ANALYSIS OF (1->3)-ß-D-GLUCAN, AND ALKALI PRETREATMENT SOLUTION FOR BIOLOGICAL SAMPLE FOR USE IN METHOD FOR IMMUNOLOGICAL ANALYSIS OF (1->3)-ß-D-GLUCAN | |
WO2020184409A1 (ja) | 生体試料中のβ-D-グルカンの免疫学的分析方法、及びβ-D-グルカン分析用キット | |
Adamczyk et al. | Pregnancy-associated changes of IgG and serum N-glycosylation in camel (camelus dromedarius) | |
US6352831B1 (en) | Glycolipid complexes and their uses | |
EP0554458B1 (en) | Immunoassay and monoclonal antibody for determining diarrheal shellfish poisons | |
CN109001453A (zh) | 一种基于胶乳免疫比浊法检测人体液样本中溶菌酶含量的试剂盒 | |
WO2005019827A1 (ja) | 大腸癌及び大腸腺腫の検査方法 | |
CN104977417A (zh) | 一种糖肽芯片及其制备方法 | |
Daniels et al. | Red cell immunohaematology | |
EP1029075B1 (en) | Sucrose detection by enzyme-linked immunosorbant assay | |
da Silva | Lectins as Biorecognition Elements in Biosensors for Clinical Applications in Cancer | |
WO2004036216A1 (ja) | 糖鎖−糖鎖結合性タンパク質の相互作用の測定方法およびその利用 | |
Chao et al. | Enrichment methods of N-linked glycopeptides from human serum or plasma: A mini-review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANG ZHILI Free format text: FORMER OWNER: SHANGHAI HUIPU BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20120129 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201400 FENGXIAN, SHANGHAI TO: 200030 XUHUI, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120129 Address after: 200030 No. 125, Xuhui District, Shanghai, Hunan Road Applicant after: Zhang Zhili Address before: 201400, room 5885, Jinhai Road, Fengxian District, Shanghai, 3051 Applicant before: SHANGHAI HUIPU BIOMEDICAL TECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160812 Address after: 201403 Building 5, building 2066, 3 hope road, Shanghai, Fengxian District Patentee after: SHANGHAI RUIANG BIOTECHNOLOGY CO.,LTD. Address before: 200030 No. 125, Xuhui District, Shanghai, Hunan Road Patentee before: Zhang Zhili |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee after: Shanghai Ruian Gene Technology Co.,Ltd. Address before: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee before: SHANGHAI RUIANG BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220228 Address after: 201403 building 3, No. 6055, Jinhai highway, Fengxian District, Shanghai Patentee after: Shanghai Ruian Gene Technology Co.,Ltd. Patentee after: CHANGCHUN JITE BIO-TECH Co.,Ltd. Address before: 201403 3rd floor, building 5, No. 2066, Wangyuan Road, Fengxian District, Shanghai Patentee before: Shanghai Ruian Gene Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |